Literature DB >> 4005121

Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage form.

D B Jack, M J Kendall, S J Laugher, S R Smith.   

Abstract

Plasma oxprenolol concentrations were measured in six young healthy female volunteers after single oral dosing with a 16/260 oxprenolol Oros system on three separate occasions. Reproducibility was assessed by comparing individual plasma profiles, areas under the curve, peak concentrations and times to peak. Plasma concentration-time profiles were consistent with an extended duration of drug release from the Oros system. Individual and mean profiles on the three occasions were similar, and no significant differences in mean plasma levels, or derived pharmacokinetic parameters, were detected. The mean amount of drug in eight systems recovered from faeces corresponded to 11% of the dose. Individual amounts were related to the total transit time of the system through the body. The 16/260 Oros system functioned reproducibly within the gastrointestinal tract, and in vivo absorption mirrored in vitro drug release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005121      PMCID: PMC1463766          DOI: 10.1111/j.1365-2125.1985.tb02760.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Absorption of drugs from the rat colon.

Authors:  L S SCHANKER
Journal:  J Pharmacol Exp Ther       Date:  1959-08       Impact factor: 4.030

2.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Measurement of the mean transit time of dietary residue through the human gut.

Authors:  J H Cummings; D J Jenkins; H S Wiggins
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

4.  Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.

Authors:  F Theeuwes; D R Swanson; G Guittard; A Ayer; S Khanna
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.

Authors:  K L Woods; D B Jack; M J Kendall; A Halsey; M L O'Donnell; S J Warrington; V A John
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.

Authors:  P N Bennett; J Bennett; I Bradbrook; J Francis; V A John; H Rogers; P Turner; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

  6 in total
  1 in total

Review 1.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.